Home  >  News
  Alchem receives European Certificate of Suitability for innovative production process to resolve stability challenge for micronized digoxin,   June 20, 2018
  Sanofi completes acquisition of Ablynx following expiration of squeeze-out procedure,   June 20, 2018
  Roche to buy outstanding shares of Foundation Medicine for USD 137 per share in cash,   June 20, 2018
  NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma,   June 19, 2018
  Novotech, CMUH Taiwan sign MoU for enhanced global trial services,   June 19, 2018
  Bristol-Myers' immuno-oncology agent, Opdivo receives Chinese approval for previously treated NSCLC,   June 19, 2018
  Certara supports MDGH to get US FDA approval for moxidectin,   June 16, 2018
  WuXi STA becomes first CDMO to support an innovative drug approval in China through the "MAH" pilot programme,   June 16, 2018
  US FDA grants orphan drug status to AMO Pharma's AMO-04 to treat Rett syndrome,   June 15, 2018
  US FDA approves Roche’s Avastin in combo with chemotherapy to treat advanced ovarian cancer following initial surgery,   June 15, 2018
  Merck’s sBLA for Gardasil 9 gets US FDA priority review status for use in women & men ages 27 to 45 for prevention of certain HPV-related cancers & diseases,   June 14, 2018
  J&J accepts binding offer from platinum equity to acquire LifeScan,   June 14, 2018
  US FDA grants fast track status to Nordic's Betalutin to treat patients with follicular lymphoma,   June 13, 2018
  Endo executes master settlement agreement allowing for resolution of known TRT product liability claims and entry of significant case management order,   June 12, 2018
  US FDA approves Roche's Venclexta in combo with Rituxan for people with previously treated CLL or SLL,   June 12, 2018
  Sanofi launches worldwide employee stock purchase plan “Action 2018”,   June 11, 2018
  Precision NanoSystems raises US$ 6 mn to speed-up product innovation & global expansion,   June 09, 2018
  Genentech's Rituxan receives US FDA approval to treat moderate to severe pemphigus vulgaris,   June 09, 2018
  Biogen inks option agreement with TMS to buy TMS-007 and backup compounds,   June 09, 2018
  US FDA grants priority review status for Pfizer's talazoparib to treat metastatic breast cancer with inherited BRCA mutation,   June 09, 2018

cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |